Search

Your search keyword '"Rubin, Mark A"' showing total 3,946 results
Start Over Author "Rubin, Mark A"
3,946 results on '"Rubin, Mark A"'

151. FIGURE 4 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Author

Van Emmenis, Lucie, primary, Ku, Sheng-Yu, primary, Gayvert, Kaitlyn, primary, Branch, Jonathan R., primary, Brady, Nicholas J., primary, Basu, Subhasree, primary, Russell, Michael, primary, Cyrta, Joanna, primary, Vosoughi, Aram, primary, Sailer, Verena, primary, Alnajar, Hussein, primary, Dardenne, Etienne, primary, Koumis, Elena, primary, Puca, Loredana, primary, Robinson, Brian D., primary, Feldkamp, Michael D., primary, Winkis, Annmarie, primary, Majewski, Nathan, primary, Rupnow, Brent, primary, Gottardis, Marco M., primary, Elemento, Olivier, primary, Rubin, Mark A., primary, Beltran, Himisha, primary, and Rickman, David S., primary

Published
2023
Full Text
View/download PDF

152. Supplementary Figure 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Author

Van Emmenis, Lucie, primary, Ku, Sheng-Yu, primary, Gayvert, Kaitlyn, primary, Branch, Jonathan R., primary, Brady, Nicholas J., primary, Basu, Subhasree, primary, Russell, Michael, primary, Cyrta, Joanna, primary, Vosoughi, Aram, primary, Sailer, Verena, primary, Alnajar, Hussein, primary, Dardenne, Etienne, primary, Koumis, Elena, primary, Puca, Loredana, primary, Robinson, Brian D., primary, Feldkamp, Michael D., primary, Winkis, Annmarie, primary, Majewski, Nathan, primary, Rupnow, Brent, primary, Gottardis, Marco M., primary, Elemento, Olivier, primary, Rubin, Mark A., primary, Beltran, Himisha, primary, and Rickman, David S., primary

Published
2023
Full Text
View/download PDF

153. FIGURE 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Author

Van Emmenis, Lucie, primary, Ku, Sheng-Yu, primary, Gayvert, Kaitlyn, primary, Branch, Jonathan R., primary, Brady, Nicholas J., primary, Basu, Subhasree, primary, Russell, Michael, primary, Cyrta, Joanna, primary, Vosoughi, Aram, primary, Sailer, Verena, primary, Alnajar, Hussein, primary, Dardenne, Etienne, primary, Koumis, Elena, primary, Puca, Loredana, primary, Robinson, Brian D., primary, Feldkamp, Michael D., primary, Winkis, Annmarie, primary, Majewski, Nathan, primary, Rupnow, Brent, primary, Gottardis, Marco M., primary, Elemento, Olivier, primary, Rubin, Mark A., primary, Beltran, Himisha, primary, and Rickman, David S., primary

Published
2023
Full Text
View/download PDF

154. Data from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Author

Van Emmenis, Lucie, primary, Ku, Sheng-Yu, primary, Gayvert, Kaitlyn, primary, Branch, Jonathan R., primary, Brady, Nicholas J., primary, Basu, Subhasree, primary, Russell, Michael, primary, Cyrta, Joanna, primary, Vosoughi, Aram, primary, Sailer, Verena, primary, Alnajar, Hussein, primary, Dardenne, Etienne, primary, Koumis, Elena, primary, Puca, Loredana, primary, Robinson, Brian D., primary, Feldkamp, Michael D., primary, Winkis, Annmarie, primary, Majewski, Nathan, primary, Rupnow, Brent, primary, Gottardis, Marco M., primary, Elemento, Olivier, primary, Rubin, Mark A., primary, Beltran, Himisha, primary, and Rickman, David S., primary

Published
2023
Full Text
View/download PDF

155. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Author

Van Emmenis, Lucie, primary, Ku, Sheng-Yu, additional, Gayvert, Kaitlyn, additional, Branch, Jonathan R., additional, Brady, Nicholas J., additional, Basu, Subhasree, additional, Russell, Michael, additional, Cyrta, Joanna, additional, Vosoughi, Aram, additional, Sailer, Verena, additional, Alnajar, Hussein, additional, Dardenne, Etienne, additional, Koumis, Elena, additional, Puca, Loredana, additional, Robinson, Brian D., additional, Feldkamp, Michael D., additional, Winkis, Annmarie, additional, Majewski, Nathan, additional, Rupnow, Brent, additional, Gottardis, Marco M., additional, Elemento, Olivier, additional, Rubin, Mark A., additional, Beltran, Himisha, additional, and Rickman, David S., additional

Published
2023
Full Text
View/download PDF

156. ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma

Author

Nocini, Riccardo, primary, Tondulli, Luca, additional, D’Ambrosio, Consuelo, additional, Luchini, Claudio, additional, Biankin, Andrew V, additional, Casolino, Raffaella, additional, Scarpa, Aldo, additional, Milella, Michele, additional, Lawlor, Rita T, additional, Stein, Lincoln D, additional, Park, Keunchil, additional, Johns, Amber L, additional, Korbel, Jan O, additional, Zeps, Nik, additional, Rubin, Mark A, additional, Marra, Marco A, additional, Elemento, Olivier, additional, Gallinger, Steven, additional, Tuveson, David, additional, Trumper, Lorenz, additional, Koch, Raphael, additional, Brennan, Paul, additional, Pilarsky, Christian, additional, Nikolaev, Sergey, additional, Yoon, Sun-Soo, additional, Lee, Eun Sook, additional, Shibata, Tatsuhiro, additional, Wu, Xiaojian, additional, Wu, Jianmin, additional, Zhan, Qimin, additional, Poon, Wai, additional, Yoshino, Takayuki, additional, Al-Kuraya, Khawla S., additional, Eeles, Rosalind, additional, Fitzgerald, Rebecca, additional, Caldas, Carlos, additional, Abraham, Jean, additional, and Chang, David K, additional

Published
2023
Full Text
View/download PDF

157. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression

Author

Papachristodoulou, Alexandros, primary, Heidegger, Isabel, additional, Virk, Renu K., additional, Di Bernardo, Matteo, additional, Kim, Jaime Y., additional, Laplaca, Caroline, additional, Picech, Florencia, additional, Schäfer, Georg, additional, De Castro, Guarionex Joel, additional, Hibshoosh, Hanina, additional, Loda, Massimo, additional, Klocker, Helmut, additional, Rubin, Mark A., additional, Zheng, Tian, additional, Benson, Mitchell C., additional, McKiernan, James M., additional, Dutta, Aditya, additional, and Abate-Shen, Cory, additional

Published
2023
Full Text
View/download PDF

158. NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer

Author

Li, Jia J, primary, Vasciaveo, Alessandro, additional, Karagiannis, Dimitrios, additional, Sun, Zhen, additional, Chen, Xiao, additional, Socciarelli, Fabio, additional, Frankenstein, Ziv, additional, Zou, Min, additional, Pannellini, Tania, additional, Chen, Yu, additional, Gardner, Kevin, additional, Robinson, Brian D, additional, de Bono, Johann, additional, Abate-Shen, Cory, additional, Rubin, Mark A, additional, Loda, Massimo, additional, Sawyers, Charles L, additional, Califano, Andrea, additional, Lu, Chao, additional, and Shen, Michael M., additional

Published
2023
Full Text
View/download PDF

165. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance

Author

Shukla, Shipra, Cyrta, Joanna, Murphy, Devan A., Walczak, Edward G., Ran, Leili, Agrawal, Praveen, Xie, Yuanyuan, Chen, Yuedan, Wang, Shangqian, Zhan, Yu, Li, Dan, Wong, Elissa W.P., Sboner, Andrea, Beltran, Himisha, Mosquera, Juan Miguel, Sher, Jessica, Cao, Zhen, Wongvipat, John, Koche, Richard P., Gopalan, Anuradha, Zheng, Deyou, Rubin, Mark A., Scher, Howard I., Chi, Ping, and Chen, Yu

Published
2017
Full Text
View/download PDF

173. Common germline-somatic variant interactions in advanced urothelial cancer

Author

Vosoughi, Aram, Zhang, Tuo, Shohdy, Kyrillus S., Vlachostergios, Panagiotis J., Wilkes, David C., Bhinder, Bhavneet, Tagawa, Scott T., Nanus, David M., Molina, Ana M., Beltran, Himisha, Sternberg, Cora N., Motanagh, Samaneh, Robinson, Brian D., Xiang, Jenny, Fan, Xiao, Chung, Wendy K., Rubin, Mark A., Elemento, Olivier, Sboner, Andrea, Mosquera, Juan Miguel, and Faltas, Bishoy M.

Published
2020
Full Text
View/download PDF

174. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Author

Cyrta, Joanna, Augspach, Anke, De Filippo, Maria Rosaria, Prandi, Davide, Thienger, Phillip, Benelli, Matteo, Cooley, Victoria, Bareja, Rohan, Wilkes, David, Chae, Sung-Suk, Cavaliere, Paola, Dephoure, Noah, Uldry, Anne-Christine, Lagache, Sophie Braga, Roma, Luca, Cohen, Sandra, Jaquet, Muriel, Brandt, Laura P., Alshalalfa, Mohammed, Puca, Loredana, Sboner, Andrea, Feng, Felix, Wang, Shangqian, Beltran, Himisha, Lotan, Tamara, Spahn, Martin, Kruithof-de Julio, Marianna, Chen, Yu, Ballman, Karla V., Demichelis, Francesca, Piscuoglio, Salvatore, and Rubin, Mark A.

Published
2020
Full Text
View/download PDF

177. Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.

Author

Bratic Hench, Ivana, Roma, Luca, Conticelli, Floriana, Bubendorf, Lenard, Calgua, Byron, Le Magnen, Clémentine, Piscuoglio, Salvatore, Rubin, Mark A., Chirindel, Alin, Nicolas, Guillaume P., Vlajnic, Tatjana, Zellweger, Tobias, Templeton, Arnoud J., Stenner, Frank, Ruiz, Christian, Rentsch, Cyrill, and Bubendorf, Lukas

Subjects
PROSTATE tumors treatment, SEQUENCE analysis, GENETIC mutation, MANN Whitney U Test, FISHER exact test, PEARSON correlation (Statistics), T-test (Statistics), GENE expression profiling, GENOMICS, DESCRIPTIVE statistics, RESEARCH funding, EXTRACELLULAR space, BODY fluid examination, PROSTATE-specific antigen, DATA analysis software, PROSTATE tumors, NUCLEIC acids
Abstract

Simple Summary: Prostate cancer (PCa) accounts for the second-highest mortality rate in cancer-associated deaths. Liquid biopsy has great potential to tailor treatment choices in advanced PCa. In this study, we evaluated the utility and diagnostic potential of a custom-designed NGS cfDNA panel based on the AmpliSeq HD Technology in advanced PCa. cfDNA somatic mutations were detected in the majority (71%) of examined advanced PCa patients. The most frequently mutated genes in the PCa cohort of 68 patients (40 metastatic castration-resistant and 28 metastatic hormone-naive PCa) were: TP53, FOXA1, SPOP, PTEN, AR, CTNNB1, RB1, and PIK3CA. AR amplifications were detected in 31% of mCRPC patients. This approach appears to be a straightforward and cost-effective method for detecting clinically relevant somatic mutations in cfDNA to aid in clinical decision-making. Most men with prostate cancer (PCa), despite potentially curable localized disease at initial diagnosis, progress to metastatic disease. Despite numerous treatment options, choosing the optimal treatment for individual patients remains challenging. Biomarkers guiding treatment sequences in an advanced setting are lacking. To estimate the diagnostic potential of liquid biopsies in guiding personalized treatment of PCa, we evaluated the utility of a custom-targeted next-generation sequencing (NGS) panel based on the AmpliSeq HD Technology. Ultra-deep sequencing on plasma circulating free DNA (cfDNA) samples of 40 metastatic castration-resistant PCa (mCRPC) and 28 metastatic hormone-naive PCa (mCSPC) was performed. CfDNA somatic mutations were detected in 48/68 (71%) patients. Of those 68 patients, 42 had matched tumor and cfDNA samples. In 21/42 (50%) patients, mutations from the primary tumor tissue were detected in the plasma cfDNA. In 7/42 (17%) patients, mutations found in the primary tumor were not detected in the cfDNA. Mutations from primary tumors were detected in all tested mCRPC patients (17/17), but only in 4/11 with mCSPC. AR amplifications were detected in 12/39 (31%) mCRPC patients. These results indicate that our targeted NGS approach has high sensitivity and specificity for detecting clinically relevant mutations in PCa. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

179. SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG

Author

Shoag, Jonathan, Liu, Deli, Blattner, Mirjam, Sboner, Andrea, Park, Kyung, Deonarine, Lesa, Robinson, Brian D., Mosquera, Juan Miguel, Chen, Yu, Rubin, Mark A., and Barbieri, Christopher E.

Subjects
Mutation -- Research, Adenocarcinoma -- Care and treatment, Prostate cancer -- Genetic aspects -- Care and treatment, Health care industry
Abstract

Nearly 50% of prostate cancers harbor gene fusions that lead to overexpression of the transcription factor ERG, while a mutually exclusive 10% of prostate cancers harbor recurrent mutations in the gene encoding the E3 ubiquitin ligase SPOP. Recent reports suggest that SPOP acts as a ubiquitin ligase for ERG and propose that ERG stabilization is the oncogenic effector of SPOP mutation. Here, we used human prostate cancer samples and showed that the vast majority of human SPOP-mutant cancers do not express ERG. Comparison of SPOP-mutant and ERG-fusion organoid models showed evidence of divergent, rather than common, transcriptional programs. Furthermore, expression of prostate cancer-associated SPOP mutations in genetically engineered mouse models of SPOP-mutant prostate cancer did not result in the expression of ERG protein in histologically normal prostate glands, high-grade prostatic intraepithelial neoplasia, invasive adenocarcinoma, or prostate organoids. In summary, we found no evidence that ERG is an effector of SPOP mutation in human prostate cancer or mouse models., Introduction Over the past decade, there has been remarkable progress in the molecular classification of prostate cancer, with the delineation of multiple distinct subclasses defined by recurrent genomic aberrations. Recurrent [...]

Published
2018
Full Text
View/download PDF

180. Differential impact of RB status on E2F1 reprogramming in human cancer

Author

McNair, Christopher, Xu, Kexin, Mandigo, Amy C., Benelli, Matteo, Leiby, Benjamin, Rodrigues, Daniel, Lindberg, Johan, Gronberg, Henrik, Crespo, Mateus, De Laere, Bram, Dirix, Luc, Visakorpi, Tapio, Li, Fugen, Feng, Felix Y., de Bono, Johann, Demichelis, Francesca, Rubin, Mark A., Brown, Myles, and Knudsen, Karen E.

Subjects
Retinoblastoma -- Research -- Development and progression, Prostate cancer -- Development and progression -- Analysis -- Research, Transcription factors -- Physiological aspects, Health care industry
Abstract

The tumor suppressor protein retinoblastoma (RB) is mechanistically linked to suppression of transcription factor E2F1 -mediated cell cycle regulation. For multiple tumor types, loss of RB function is associated with poor clinical outcome. RB action is abrogated either by direct depletion or through inactivation of RB function; however, the basis for this selectivity is unknown. Here, analysis of tumor samples and cell-free DNA from patients with advanced prostate cancer showed that direct RB loss was the preferred pathway of disruption in human disease. While RB loss was associated with lethal disease, RB-deficient tumors had no proliferative advantage and exhibited downstream effects distinct from cell cycle control. Mechanistically, RB loss led to E2F1 cistrome expansion and different binding specificity, alterations distinct from those observed after functional RB inactivation. Additionally, identification of protumorigenic transcriptional networks specific to RB loss that were validated in clinical samples demonstrated the ability of RB loss to differentially reprogram E2F1 in human cancers. Together, these findings not only identify tumor-suppressive functions of RB that are distinct from cell cycle control, but also demonstrate that the molecular consequence of RB loss is distinct from RB inactivation. Thus, these studies provide insight into how RB loss promotes disease progression, and identify new nodes for therapeutic intervention., Introduction The function of the retinoblastoma tumor suppressor (RB) in preventing tumor development relies in large part on the capacity of this transcriptional corepressor to modulate E2F family transcription factor [...]

Published
2018
Full Text
View/download PDF

182. Telestroke

Author

Rubin, Mark N., Demaerschalk, Bart M., Schwamm, Lee H., Wechsler, Lawrence R., Tsao, Jack W., editor, and Demaerschalk, Bart M., editor

Published
2015
Full Text
View/download PDF

185. Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission

Author

Casolino, Raffaella, Johns, Amber L, Courtot, Melanie, Lawlor, Rita T, De Lorenzo, Francesco, Horgan, Denis, Mateo, Joaquin, Normanno, Nicola, Rubin, Mark, Stein, Lincoln, Subbiah, Vivek, Westphalen, Benedikt C, Lawler, Mark, Park, Keunchil, Perdomo, Sandra, Yoshino, Takayuki, Wu, Jianmin, and Biankin, Andrew V

Subjects
Oncology, 610 Medizin und Gesundheit
Published
2023
Full Text
View/download PDF

187. Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey

Author

Fine, Samson W., Trpkov, Kiril, Amin, Mahul B., Algaba, Ferran, Aron, Manju, Baydar, Dilek E., Beltran, Antonio Lopez, Brimo, Fadi, Cheville, John C., Colecchia, Maurizio, Comperat, Eva, Costello, Tony, da Cunha, Isabela Werneck, Delprado, Warick, DeMarzo, Angelo M., Giannico, Giovanna A., Gordetsky, Jennifer B., Guo, Charles C., Hansel, Donna E., Hirsch, Michelle S., Huang, Jiaoti, Humphrey, Peter A., Jimenez, Rafael E., Khani, Francesca, Kong, Max X., Kryvenko, Oleksandr N., Kunju, L. Priya, Lal, Priti, Latour, Mathieu, Lotan, Tamara, Maclean, Fiona, Magi-Galluzzi, Cristina, Mehra, Rohit, Menon, Santosh, Miyamoto, Hiroshi, Montironi, Rodolfo, Netto, George J., Nguyen, Jane K., Osunkoya, Adeboye O., Parwani, Anil, Pavlovich, Christian P., Robinson, Brian D., Rubin, Mark A., Shah, Rajal B., So, Jeffrey S., Takahashi, Hiroyuki, Tavora, Fabio, Tretiakova, Maria S., True, Lawrence, Wobker, Sara E., Yang, Ximing J., Zhou, Ming, Zynger, Debra L., and Epstein, Jonathan I.

Published
2021
Full Text
View/download PDF

188. The long tail of oncogenic drivers in prostate cancer

Author

Armenia, Joshua, Wankowicz, Stephanie A. M., Liu, David, Gao, Jianjiong, Kundra, Ritika, Reznik, Ed, Chatila, Walid K., Chakravarty, Debyani, Han, G. Celine, Coleman, Ilsa, Montgomery, Bruce, Pritchard, Colin, Morrissey, Colm, Barbieri, Christopher E., Beltran, Himisha, Sboner, Andrea, Zafeiriou, Zafeiris, Miranda, Susana, Bielski, Craig M., Penson, Alexander V., Tolonen, Charlotte, Huang, Franklin W., Robinson, Dan, Wu, Yi Mi, Lonigro, Robert, Garraway, Levi A., Demichelis, Francesca, Kantoff, Philip W., Taplin, Mary-Ellen, Abida, Wassim, Taylor, Barry S., Scher, Howard I., Nelson, Peter S., de Bono, Johann S., Rubin, Mark A., Sawyers, Charles L., Chinnaiyan, Arul M., PCF/SU2C International Prostate Cancer Dream Team, Schultz, Nikolaus, and Van Allen, Eliezer M.

Published
2018
Full Text
View/download PDF

190. Migrants, asylum seekers, and refugees: Different labels for immigrants influence attitudes through perceived benefits in nine countries

Author

Graf, Sylvie, primary, Rubin, Mark, additional, Assilamehou‐Kunz, Yvette, additional, Bianchi, Mauro, additional, Carnaghi, Andrea, additional, Fasoli, Fabio, additional, Finell, Eerika, additional, Gustafsson Sendén, Marie, additional, Shamloo, Soraya Elizabeth, additional, Tocik, Jaroslav, additional, Lacko, David, additional, and Sczesny, Sabine, additional

Published
2023
Full Text
View/download PDF

197. Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

Author

Gallon, John, primary, Rodriguez-Calero, Antonio, primary, Benjak, Andrej, primary, Akhoundova, Dilara, primary, Maletti, Sina, primary, Amstutz, Ursula, primary, Hewer, Ekkehard, primary, Genitsch, Vera, primary, Fleischmann, Achim, primary, Rushing, Elisabeth J., primary, Grobholz, Rainer, primary, Fischer, Ingeborg, primary, Jochum, Wolfram, primary, Cathomas, Gieri, primary, Osunkoya, Adeboye O., primary, Bubendorf, Lukas, primary, Moch, Holger, primary, Thalmann, George, primary, Feng, Felix Y., primary, Gillessen, Silke, primary, Ng, Charlotte K.Y., primary, Rubin, Mark A., primary, and Piscuoglio, Salvatore, primary

Published
2023
Full Text
View/download PDF

198. Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

Author

Gallon, John, primary, Rodriguez-Calero, Antonio, primary, Benjak, Andrej, primary, Akhoundova, Dilara, primary, Maletti, Sina, primary, Amstutz, Ursula, primary, Hewer, Ekkehard, primary, Genitsch, Vera, primary, Fleischmann, Achim, primary, Rushing, Elisabeth J., primary, Grobholz, Rainer, primary, Fischer, Ingeborg, primary, Jochum, Wolfram, primary, Cathomas, Gieri, primary, Osunkoya, Adeboye O., primary, Bubendorf, Lukas, primary, Moch, Holger, primary, Thalmann, George, primary, Feng, Felix Y., primary, Gillessen, Silke, primary, Ng, Charlotte K.Y., primary, Rubin, Mark A., primary, and Piscuoglio, Salvatore, primary

Published
2023
Full Text
View/download PDF

199. Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework

Author

Vasciaveo, Alessandro, primary, Arriaga, Juan Martín, primary, de Almeida, Francisca Nunes, primary, Zou, Min, primary, Douglass, Eugene F., primary, Picech, Florencia, primary, Shibata, Maho, primary, Rodriguez-Calero, Antonio, primary, de Brot, Simone, primary, Mitrofanova, Antonina, primary, Chua, Chee Wai, primary, Karan, Charles, primary, Realubit, Ronald, primary, Pampou, Sergey, primary, Kim, Jaime Y., primary, Afari, Stephanie N., primary, Mukhammadov, Timur, primary, Zanella, Luca, primary, Corey, Eva, primary, Alvarez, Mariano J., primary, Rubin, Mark A., primary, Shen, Michael M., primary, Califano, Andrea, primary, and Abate-Shen, Cory, primary

Published
2023
Full Text
View/download PDF

200. Table S4 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

Author

Vasciaveo, Alessandro, primary, Arriaga, Juan Martín, primary, de Almeida, Francisca Nunes, primary, Zou, Min, primary, Douglass, Eugene F., primary, Picech, Florencia, primary, Shibata, Maho, primary, Rodriguez-Calero, Antonio, primary, de Brot, Simone, primary, Mitrofanova, Antonina, primary, Chua, Chee Wai, primary, Karan, Charles, primary, Realubit, Ronald, primary, Pampou, Sergey, primary, Kim, Jaime Y., primary, Afari, Stephanie N., primary, Mukhammadov, Timur, primary, Zanella, Luca, primary, Corey, Eva, primary, Alvarez, Mariano J., primary, Rubin, Mark A., primary, Shen, Michael M., primary, Califano, Andrea, primary, and Abate-Shen, Cory, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results